Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
A Morgan Stanley survey shows that U.S. vet practices are growing sales by raising prices as they contend with fewer visits ...
Refinancing to a lower rate isn’t an option for many homeowners, who now face “financially unsustainable” mortgage payments.
Prologis said Wednesday that it is offering 0.092 new shares for each Segro share tendered. Its latest offer values the U.K. company at 10.32 pounds a share, or 3.9% more than its ...
The Dow Jones Industrial Average held onto a modest gain as trading Wednesday headed into its final hour and tech stocks continued to decline, pulling the Nasdaq Composite lower. The S&P 500 struggled ...
NovaGold Resources has struck a deal to take full ownership of the Donlin Gold project by buying investment firm Paulson's 40% stake that will create a large U.S. gold development company. The ...
Tesla's stock is heading toward the earnings report not in the best technical shape, based on what its chart is saying. First, both the 50-day moving average -- viewed as a short-term trend tracker -- ...
The Dow Jones Industrial Average, S&P 500 and Nasdaq Composite all traded modestly lower ahead of Wednesday's close, with investors "holding their breathe before the report card comes home and hits ...
The blank-check company will give public shareholders the right to redeem their shares at the business combination, with a 15% cap per holder acting in concert, and has 12 months ...
Energy stocks are rising Wednesday along with global oil prices as the U.S. and Iran threaten to escalate the Middle East conflict. The S&P 500's energy sector was up 1.3%, while its materials sector ...
14h
Stocks mostly higher in early afternoon trading, with utilities and materials among sector gainers
The Dow Jones Industrial Average and S&P 500 were both trading higher Wednesday afternoon, but the Nasdaq composite continued to edge lower, with shares of Microsoft and Meta each down over 2%. The ...
Repligen has struck a deal to buy cell-processing tools developer BioLife Solutions for about $1.5 billion in cash and stock in a deal that bolsters the life-sciences company's position in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results